Charity fundraisers rush to meet Amgen deadline
With a week left to match a challenge from the Amgen Foundation, a fund drive paying for basic needs of Ventura County residents has raised more than $130,000.The money is being given to Th...
Ventura County Star,
Thu Nov 26 18:19:00 PST 2009
• Found on Yahoo! News
Midday Glance: Biotechnology companies
NEW YORK (AP) -- Shares of some top biotechnology companies are down at noon: Amgen fell $.36 or .6 percent, to $56.72. Biogen Idec fell $.20 or .4 percent, to $47.25. Celgene fell $.25 or ...
AP via Yahoo! Finance,
Fri Nov 27 10:02:47 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Early Glance: Biotechnology companies
NEW YORK (AP) -- Shares of some top biotechnology companies are down at 10 a.m.: Amgen fell $.67 or 1.2 percent, to $56.41. Biogen Idec fell $.54 or 1.1 percent, to $46.91. Celgene fell $.9...
AP via Yahoo! Finance,
Fri Nov 27 07:46:57 PST 2009
• Found on Yahoo! News
Midday Glance: Biotechnology companies
Amgen fell $.36 or .6 percent, to $56.72. Biogen Idec fell $.20 or .4 percent, to $47.25.
INO News,
Fri Nov 27 10:16:12 PST 2009
• Found on Yahoo! News
Early Glance: Biotechnology companies
(AP:NEW YORK) Shares of some top biotechnology companies are down at 10 a.m.: Amgen fell $.67 or 1.2 percent, to $56.41. Biogen Idec fell $.54 or 1.1 percent, to $46.91.
INO News,
Fri Nov 27 08:01:33 PST 2009
• Found on Yahoo! News
Suit alleges Medicare fraud by drug company
The allegations in the lawsuit are shocking.
Beaumont Enterprise,
Sun Nov 29 01:56:31 PST 2009
• Found on Yahoo! News
12 Years Of Patent Protection For Biologics Based Research And Development Creates...
67 WALL STREET, New York - November 28, 2009 - The Wall Street Transcript has recently published its Q4 2009 Biotechnology Report offering a timely review of the sector to serious investors...
Wall Street Transcript via Yahoo! Finance,
Sat Nov 28 07:34:00 PST 2009
• Found on Yahoo! News
ImmunoGen licenses Amgen right to use TAP technology to develop anticancer therape...
ImmunoGen, Inc, a biotechnology company that develops targeted anticancer products, announced that Amgen Inc. has licensed the exclusive right to use the company's maytansinoid Targeted Ant...
PharmaBiz,
Tue Nov 24 00:51:25 PST 2009
• Found on Yahoo! News
NASA Spaceline Current Awareness 30 October 2009
NASA Spaceline Current Awareness 30 October 2009
SpaceRef,
Sat Nov 28 12:29:19 PST 2009
• Found on Yahoo! News
Relabeling May Guide Retrospective Data Criteria
The conditions under which the US Food and Drug Administration accepted retrospective analyses from two pharmaceutical companies in updating labeling for a class of colorectal cancer drugs ...
GenomeWeb News,
Sat Nov 28 06:45:33 PST 2009
• Found on Yahoo! News
Is Gene-Therapy Medical Treatment Ready for Prime Time?
After years of complications and high-profile setbacks, a series of small but intriguing advances has suggested that gene therapy may hold real future potential for treatment
Time Magazine,
Fri Nov 27 02:40:08 PST 2009
• Found on Yahoo! News
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate® , at a Nov. 18 ceremony in London.
PR Newswire via Yahoo! Finance,
Mon Nov 23 12:05:00 PST 2009
• Found on Yahoo! News
Final Glance: Biotechnology companies
NEW YORK (AP) -- Shares of some top biotechnology companies were up at the close of trading: Amgen rose $.28 or .5 percent, to $57.08. Biogen Idec rose $.07 or .1 percent, to $47.45. Celgen...
AP via Yahoo! Finance,
Wed Nov 25 14:44:19 PST 2009
• Found on Yahoo! News
This Big Winner Has Hit Its Prime
There are still a few ways to benefit from Primecap's expertise.
The Motley Fool,
Fri Nov 27 08:27:45 PST 2009
• Found on Yahoo! News
Midday Glance: Biotechnology companies
NEW YORK (AP) -- Shares of some top biotechnology companies are mixed at noon: Amgen rose $.56 or 1.0 percent, to $57.36. Biogen Idec rose $.01 or percent, to $47.39. Celgene rose $.23 or ....
AP via Yahoo! Finance,
Wed Nov 25 10:08:24 PST 2009
• Found on Yahoo! News
Details emerge about possible Tour of California routes through Grass Valley
While Amgen Tour staffers were scouting county roads Wednesday, local officials met in the hope the Tour of California would weave through downtown Grass Valley. The route will not be decid...
The Grass Valley Union,
Thu Nov 26 02:13:55 PST 2009
• Found on Yahoo! News
Early Glance: Biotechnology companies
NEW YORK (AP) -- Shares of some top biotechnology companies are mixed at 10 a.m.: Amgen rose $.69 or 1.2 percent, to $57.49. Biogen Idec rose $.01 or percent, to $47.39. Celgene fell $.03 o...
AP via Yahoo! Finance,
Wed Nov 25 07:23:22 PST 2009
• Found on Yahoo! News
INSIDE WASHINGTON: Stream of WH health care visits
President Barack Obama's top aides met frequently with lobbyists and health care industry heavyweights as his administration pieced together a national health care overhaul, according to Wh...
AP via Yahoo! News,
Thu Nov 26 13:11:09 PST 2009
• Found on Yahoo! News
Put Sellers Swarm AGCO Corporation (AGCO) on China Investment
AGCO Corporation (AGCO: sentiment, chart, options) recently announced plans to invest %24100 million in China over the next three to four years, with two new manufacturing plants expected t...
Schaeffers Research,
Fri Nov 27 07:38:55 PST 2009
• Found on Yahoo! News